Marksans Pharma strengthens European presence with €7.5 million QliniQ acquisition - CNBC TV18
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
PharmaCorp Rx has acquired PharmaChoice Canada bannered pharmacy, a pharmacy business in Ontario, for $8.2 million. PharmaChoice Canada bannered pharmacy operates a pharmacist-led community pharmacy model in Morrisburg, supporting local dispensing and patient services. PharmaCorp Rx acquisitions expand the company’s pharmacy footprint in Eastern Canada by adding a PharmaChoice Canada bannered location to its store network. The healthcare M&A deal is an add-on acquisition by a strategic buyer, converting previously announced letters of intent into a definitive share purchase agreement, with completion expected to increase PharmaCorp Rx’s store count to 15.
Filed under
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Marksans Pharma→Teva Pharmaceuticals Ireland and Teva Pharmaceuticals Canada
Jun 1, 2026
Marksans Pharma→QliniQ
Jun 1, 2026
Frazier Healthcare Partners→Altruix
May 31, 2026
Signos
May 31, 2026
Sterling Bay→Pacific Center
May 29, 2026